Tealwood Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Buy |
21,563
+5,874
| +37% | +$323K | 0.53% | 102 |
|
|
2025
Q1 | $1.11M | Buy |
15,689
+156
| +1% | +$11K | 0.51% | 99 |
|
|
2024
Q4 | $1.02M | Sell |
15,533
-117
| -0.7% | -$7.69K | 0.42% | 111 |
|
|
2024
Q3 | $1.1M | Buy |
15,650
+3,503
| +29% | +$246K | 0.48% | 111 |
|
|
2024
Q2 | $1M | Sell |
12,147
-54
| -0.4% | -$4.45K | 0.6% | 84 |
|
|
2024
Q1 | $1.07M | Sell |
12,201
-225
| -2% | -$19.7K | 0.48% | 108 |
|
|
2023
Q4 | $1.2M | Sell |
12,426
-323
| -3% | -$31.1K | 0.57% | 91 |
|
|
2023
Q3 | $1.13M | Sell |
12,749
-274
| -2% | -$24.2K | 0.58% | 89 |
|
|
2023
Q2 | $1.13M | Sell |
13,023
-233
| -2% | -$20.2K | 0.55% | 98 |
|
|
2023
Q1 | $1.29M | Sell |
13,256
-157
| -1% | -$15.3K | 0.66% | 70 |
|
|
2022
Q4 | $1.39M | Sell |
13,413
-1,146
| -8% | -$119K | 0.73% | 59 |
|
|
2022
Q3 | $1.23M | Sell |
14,559
-43
| -0.3% | -$3.65K | 0.67% | 64 |
|
|
2022
Q2 | $1.21M | Sell |
14,602
-368
| -2% | -$30.5K | 0.6% | 76 |
|
|
2022
Q1 | $1.15M | Sell |
14,970
-244
| -2% | -$18.8K | 0.49% | 106 |
|
|
2021
Q4 | $1.34M | Buy |
+15,214
| New | +$1.34M | 0.54% | 92 |
|